Pfizer

News

Pfizer eyes gastro use for Xeljanz after thumbs-up from FDA ...

Pfizer has been steadily building a franchise around its inflammatory diseases pill, Xeljanz (tofacitinib) over the last few years, and it could add another use after US experts recommended

News

BMS seizes Opdivo dosing advantage over Keytruda

Bristol-Myers Squibb has scored a victory against arch-rivals Merck, with a new much more convenient dosing schedule for Opdivo which could help it keep ahead in the sales race.

News

Pfizer might buy BMS for $130bn – but should it?

Pfizer could soon launch a multi-billion dollar bid for immunotherapy rivals Bristol-Myers Squibb.

News

J&J gets quick approval for new next-gen prostate cancer dru...

The FDA has approved Johnson & Johnson’s next generation prostate cancer drug, apalutamide in an early but tough to treat form of prostate cancer that has not spread.

News